Search For "bharat biotech"
Brazil to suspend Covaxin vaccine deal
Updated : 4 years, 9 months ago IST
Brasilia [Brazil], June 30 (ANI): Amid a probe into accusations of irregularities against President Jair Bolsonaro, Brazil's health minister has announced that the country will suspend a USD 324 million contract to buy 20 million doses of Bharat Biotech's Covaxin.
Read More
Union Minister Mansukh Mandaviya reviews COVID-19 vaccines production in H
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], June 27 (ANI): Union Minister of State for Chemicals and Fertilisers Mansukh Mandaviya along with Minister of State for Home Affairs G Kishan Reddy on Sunday reviewed production of COVID-19 vaccines in Hyderabad.
Read More
India likely to have COVID vaccine for children above 2 years by September
Updated : 4 years, 9 months ago IST
New Delhi [India], June 23 (ANI): Noting that children usually have a mild disease but there is a need to develop COVID-19 vaccines for them, AIIMS Delhi Director Dr Randeep Guleria has said Bharat Biotech and other companies are doing trials at a very fast pace and hoped that data will l
Read More
DCGI likely to approve phase 3 trial data of Covaxin on Tuesday
Updated : 4 years, 9 months ago IST
New Delhi [India], June 22 (ANI): The Drugs Controller General of India (DCGI) is likely to approve Phase III trial data of Covaxin on Tuesday, sources said.
Read More
Bharat Biotech's Covaxin shows 77.8 pc efficacy in Phase III trials, say s
Updated : 4 years, 9 months ago IST
New Delhi [India], June 22 (ANI): Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday, according to sources.
Read More
DCGI's expert panel to review Phase III data of Covaxin today
Updated : 4 years, 9 months ago IST
New Delhi [India], June 22 (ANI): The Subject Expert Committee (SEC) under the drug regulator will discuss reviewing the Phase III data of Bharat Biotech's Covaxin on Tuesday.
Read More
Bharat Biotech has submitted Covaxin's Phase III trial data to DCGI: Govt
Updated : 4 years, 9 months ago IST
New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India (DCGI) over the weekend, according to government sources.
Read More
Bharat Biotech, WHO pre-submission meeting on June 23: WHO
Updated : 4 years, 9 months ago IST
New Delhi [India], June 17 (ANI): Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use Listing (EUL) of its indigenous COVID-19 vaccine Covaxin.
Read More
Covid-19: No newborn calf serum in final Covaxin product, says Health mini
Updated : 4 years, 9 months ago IST
New Delhi [India], June 16 (ANI): The Union Health Ministry on Wednesday said that newborn calf serum is not an ingredient of the final Covaxin vaccine by Bharat Biotech.
Read More
Rs 150 per dose is not sustainable in long run: Bharat Biotech on Centre's
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], June 15 (ANI): Indigenous COVID-19 vaccine maker Bharat Biotech on Tuesday said the supply price of Covaxin to the Government of India at Rs 150 per dose is a non-competitive price and not sustainable in the long run, hence a higher price in private markets is
Read More
AIIMS Delhi to start screening children aged 6-12 yrs for Covaxin trials f
Updated : 4 years, 9 months ago IST
New Delhi [India], June 14 (ANI): The screening of children aged 6 to 12 years for the clinical trials of indigenously developed Covid-19 vaccine, Bharat Biotech's Covaxin is scheduled to start from Tuesday.
Read More
Bharat Biotech to undertake clinical trials in US
Updated : 4 years, 9 months ago IST
New Delhi [India], June 12 (ANI): India's first indigenous COVID-19 vaccine manufacturer Bharat Biotech on Saturday said that it will be carrying out clinical trials in the US to support the marketing application for Covaxin in the country.
Read More